Phase I evaluation of paclitaxel poliglumex (PPX) administered weekly for patients with advanced cancer.

被引：0
|
作者：
Takimoto, CH
Verschraegen, C
Young, D
Oldham, FB
Bernareggi, A
Rowinsky, EK
机构：
[1] CTRC, Inst Drug Dev, San Antonio, TX USA
[2] Univ New Mexico, Canc Therapy & Res Ctr, Albuquerque, NM 87131 USA
[3] Multicare Hlth Syst Med Oncol Clin, Tacoma, WA USA
[4] Cell Therapeut Inc, Seattle, WA USA
来源：
CLINICAL CANCER RESEARCH | 2005年 / 11卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9118S / 9118S
页数：1
相关论文
共 50 条
  • [1] Phase I evaluation of paclitaxel poliglumex (PPX) administered weekly for patients with advanced cancer.
    Takimoto, CH
    Schwartz, G
    Romero, O
    Patnaik, A
    Tolcher, A
    Garrison, M
    Oldham, FB
    Bernareggi, A
    Rowinsky, E
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 145S - 145S
  • [2] A phase I study of paclitaxel poliglumex (PPX) in combination with cisplatin (CIS) for patients (pts) with advanced cancer.
    Skubitz, KM
    Verschraegen, CF
    Daud, A
    Bernareggi, A
    Oldham, FB
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 157S - 157S
  • [3] Phase I study of paclitaxel poliglumex administered weekly for patients with advanced solid malignancies
    Mita, Monica
    Mita, Alain
    Sarantopoulos, John
    Takimoto, Chris H.
    Rowinsky, Eric K.
    Romero, Ofelia
    Angiuli, Patrizia
    Allievi, Cecilia
    Eisenfeld, Amy
    Verschraegen, Claire F.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 287 - 295
  • [4] Phase I study of paclitaxel poliglumex administered weekly for patients with advanced solid malignancies
    Monica Mita
    Alain Mita
    John Sarantopoulos
    Chris H. Takimoto
    Eric K. Rowinsky
    Ofelia Romero
    Patrizia Angiuli
    Cecilia Allievi
    Amy Eisenfeld
    Claire F. Verschraegen
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 287 - 295
  • [5] Paclitaxel poliglumex (PPX), cisplatin and concurrent radiation for esophageal and gastric cancer: A phase I study
    Dipetrillo, T.
    Evans, D.
    Akerman, P.
    Miner, T.
    Millis, R.
    Jean, M.
    Henderson, D.
    Oldham, F.
    Eisenfeld, A.
    Safran, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Paclitaxel poliglumex (PPX-xyotax) and concurrent radiation for esophageal and gastric cancer - A phase I study
    Dipetrillo, Tom
    Milas, Luka
    Evans, Devon
    Akerman, Paul
    Ng, Thomas
    Miner, Tom
    Cruff, Dennis
    Chauhan, Bharti
    Iannitti, David
    Harrington, David
    Safran, Howard
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (04): : 376 - 379
  • [7] A phase I/II study of radiation therapy, paclitaxel poliglumex, and cetuximab in locally advanced head and neck cancer.
    Hahn, Seung Shin
    Bogart, Jeffrey
    Chung, Taik Chung
    Hsu, Jack
    Kellman, Robert
    Kim, Jung-Ah
    Graziano, Steve
    Martin, Dena
    Gajra, Ajeet
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Weekly cisplatin-epirubicin-paclitaxel in advanced breast cancer. A phase I study
    Frasci, G
    Comella, P
    Apicella, A
    D'Aiuto, G
    Thomas, R
    Capasso, I
    Di Bonito, M
    Piccolo, S
    Carteni, G
    Gravina, A
    Comella, G
    ANNALS OF ONCOLOGY, 1998, 9 : 98 - 98
  • [9] Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer
    Fennelly, D
    Aghajanian, C
    Shapiro, F
    OFlaherty, C
    McKenzie, M
    OConnor, C
    Tong, W
    Norton, L
    Spriggs, D
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) : 187 - 192
  • [10] Phase I study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer.
    Ueda, Y
    Yamagishi, H
    Ichikawa, D
    Koizumi, K
    Morii, J
    Takenaka, A
    Shimotsuma, M
    Kurioka, H
    Yamashita, T
    Sakamoto, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 368S - 368S
12345